New blood thinner combo tested in heart patients

NCT ID NCT00508924

Completed Disease control Sponsor: Tanabe Pharma Corporation Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated May 22, 2026 · Updated 23 times

Summary

This study tested three doses of a blood thinner called argatroban, given with clopidogrel and aspirin, in 140 people with stable heart disease or unstable angina who needed a procedure to open blocked heart arteries. The goal was to see how well argatroban prevents blood clots and causes bleeding compared to the standard blood thinner, heparin. The study measured clotting time and tracked deaths, heart attacks, urgent procedures, and major bleeding for 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Study site

Aalst, Belgium
Study site

Bad Nauheim, Germany
Study site

Cologne, Germany
Study site

Dachau, Germany
Study site

Düren, Germany
Study site

Frankfurt, Germany
Study site

Halle, Germany
Study site

Mainz, Germany

Conditions

Explore the condition pages connected to this study.

ANGINA, UNSTABLE CORONARY ARTERY DISEASE